A Study Evaluating the Presence and Concentration of BRIUMVI™ (Ublituximab) in Breast Milk

Study Summary

The primary objective of the lactation study is to characterize the presence and concentration of BRIUMVI™ in breast milk among breastfeeding participants who receive BRIUMVI™ therapeutically for the treatment of relapsing forms of multiple sclerosis (RMS).

Conditions

Relapsing Multiple Sclerosis

Interventions / Drugs

No intervention

View on ClinicalTrials.gov ↗

Sponsor

Study Details

Enrollment16 participants

Primary Completion—

Lead SponsorTG Therapeutics, Inc.

Data Retrieved2026-04-11 04:29:09.137929+00:00

Not financial advice. BiotechSigns data is sourced from ClinicalTrials.gov, SEC EDGAR, and other public databases for research and informational purposes only. It does not constitute investment recommendations. Always do your own due diligence before making investment decisions.